These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8804246)

  • 1. Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis.
    Hansen-Schmidt S; Silomon J; Keller F
    Am J Kidney Dis; 1996 Sep; 28(3):451-3. PubMed ID: 8804246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin-induced osmotic nephrosis.
    Ahsan N; Palmer BF; Wheeler D; Greenlee RG; Toto RD
    Arch Intern Med; 1994 Sep; 154(17):1985-7. PubMed ID: 8074604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute renal failure following immunoglobulin therapy.
    Ahsan N; Wiegand LA; Abendroth CS; Manning EC
    Am J Nephrol; 1996; 16(6):532-6. PubMed ID: 8955767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osmotic nephropathy resulting from maltose-based intravenous immunoglobulin therapy.
    Chacko B; John GT; Balakrishnan N; Kirubakaran MG; Jacob CK
    Ren Fail; 2006; 28(2):193-5. PubMed ID: 16538981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin and the kidney--a two-edged sword.
    Orbach H; Tishler M; Shoenfeld Y
    Semin Arthritis Rheum; 2004 Dec; 34(3):593-601. PubMed ID: 15609263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes.
    Dickenmann M; Oettl T; Mihatsch MJ
    Am J Kidney Dis; 2008 Mar; 51(3):491-503. PubMed ID: 18295066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute renal failure after large doses of intravenous immune globulin.
    Haskin JA; Warner DJ; Blank DU
    Ann Pharmacother; 1999; 33(7-8):800-3. PubMed ID: 10466908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute renal failure and intravenous immune globulin: sucrose nephropathy in disguise?
    Perazella MA; Cayco AV
    Am J Ther; 1998 Nov; 5(6):399-403. PubMed ID: 10099084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute renal failure related to intravenous immunoglobulin infusion in an elderly woman.
    Kwan TH; Tong MK; Siu YP; Leung KT; Lee HK; Yung CY; Au TC
    Hong Kong Med J; 2005 Feb; 11(1):45-9. PubMed ID: 15687516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute renal failure in acquired haemophilia following the use of high dose intravenous immunoglobulin.
    Laidlaw S; Bainton R; Wilkie M; Makris M
    Haemophilia; 1999 Jul; 5(4):270-2. PubMed ID: 10469182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report.
    Winward DB; Brophy MT
    Pharmacotherapy; 1995; 15(6):765-72. PubMed ID: 8602385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complications of osmotic nephrosis after perfusion urography in renal insufficiency].
    Kleinknecht D; Jungers P; Michel JR; Philippe B; Nabarra B; Hinglais N
    Ann Med Interne (Paris); 1971 Nov; 122(11):1167-71. PubMed ID: 5150320
    [No Abstract]   [Full Text] [Related]  

  • 13. Macrophagelike vacuolated renal tubular cells in the urine of a male with osmotic nephrosis associated with intravenous immunoglobulin therapy. A case report.
    Khalil M; Shin HJ; Tan A; DuBose TD; Ordóñez N; Katz RL
    Acta Cytol; 2000; 44(1):86-90. PubMed ID: 10667167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute renal failure associated with immunoglobulin therapy.
    Cantú TG; Hoehn-Saric EW; Burgess KM; Racusen L; Scheel PJ
    Am J Kidney Dis; 1995 Feb; 25(2):228-34. PubMed ID: 7847349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osmotic nephrosis in a renal transplant recipient.
    Ebcioglu Z; Cohen DJ; Crew RJ; Hardy MA; Ratner LE; D'Agati VD; Markowitz GS
    Kidney Int; 2006 Nov; 70(10):1873-6. PubMed ID: 16883320
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous immunoglobulins: in-depth review of excipients and acute kidney injury risk.
    Dantal J
    Am J Nephrol; 2013; 38(4):275-84. PubMed ID: 24051350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal safety of high-dose, sucrose-free intravenous immunoglobulin in kidney transplant recipients: an observational study.
    Luque Y; Anglicheau D; Rabant M; El Karoui K; Jamme M; Aubert O; Clément R; Noël LH; Bollée G; Brodin-Sartorius A; Martinie M; Kreis H; Timsit MO; Legendre C
    Transpl Int; 2016 Nov; 29(11):1205-1215. PubMed ID: 27529401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin-associated acute renal failure: case series and literature review.
    Itkin YM; Trujillo TC
    Pharmacotherapy; 2005 Jun; 25(6):886-92. PubMed ID: 15927908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms Underlying Exacerbation of Osmotic Nephrosis Caused by Pre-existing Kidney Injury.
    Matsushita K; Takasu S; Kuroda K; Ishii Y; Kijima A; Ogawa K; Umemura T
    Toxicol Sci; 2018 Oct; 165(2):420-430. PubMed ID: 29947792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal toxicity of intravenous immunoglobulin.
    Stewart RR; Winney RJ; Cash JD
    Vox Sang; 1993; 65(3):244. PubMed ID: 8249370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.